Raymond James Trust’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.69M | Buy |
5,180
+195
| +4% | +$104K | 0.06% | 281 |
|
|
2024
Q2 | $2.7M | Sell |
4,985
-265
| -5% | -$140K | 0.06% | 258 |
|
|
2024
Q1 | $2.72M | Buy |
5,250
+5
| +0.1% | +$2.49K | 0.07% | 255 |
|
|
2023
Q4 | $2.47M | Buy |
5,245
+55
| +1% | +$25.4K | 0.07% | 254 |
|
|
2023
Q3 | $2.26M | Buy |
5,190
+312
| +6% | +$142K | 0.07% | 243 |
|
|
2023
Q2 | $2.17M | Sell |
4,878
-200
| -4% | -$92.3K | 0.06% | 257 |
|
|
2023
Q1 | $2.33M | Buy |
5,078
+303
| +6% | +$144K | 0.07% | 229 |
|
|
2022
Q4 | $2.45M | Sell |
4,775
-221
| -4% | -$112K | 0.08% | 220 |
|
|
2022
Q3 | $2.27M | Buy |
4,996
+576
| +13% | +$276K | 0.08% | 215 |
|
|
2022
Q2 | $2.13M | Sell |
4,420
-468
| -10% | -$232K | 0.08% | 237 |
|
|
2022
Q1 | $2.4M | Buy |
4,888
+813
| +20% | +$372K | 0.07% | 234 |
|
|
2021
Q4 | $1.89M | Buy |
4,075
+374
| +10% | +$157K | 0.06% | 275 |
|
|
2021
Q3 | $1.38M | Buy |
3,701
+204
| +6% | +$77.5K | 0.05% | 319 |
|
|
2021
Q2 | $1.33M | Buy |
3,497
+150
| +4% | +$57.3K | 0.04% | 322 |
|
|
2021
Q1 | $1.2M | Sell |
3,347
-287
| -8% | -$92.3K | 0.04% | 322 |
|
|
2020
Q4 | $1.17M | Sell |
3,634
-328
| -8% | -$101K | 0.04% | 319 |
|
|
2020
Q3 | $1.06M | Buy |
3,962
+228
| +6% | +$61.3K | 0.05% | 303 |
|
|
2020
Q2 | $982K | Buy |
3,734
+280
| +8% | +$74.7K | 0.05% | 308 |
|
|
2020
Q1 | $784K | Buy |
3,454
+307
| +10% | +$83.7K | 0.05% | 310 |
|
|
2019
Q4 | $950K | Sell |
3,147
-250
| -7% | -$68.8K | 0.05% | 314 |
|
|
2019
Q3 | $815K | Buy |
3,397
+328
| +11% | +$89.9K | 0.04% | 348 |
|
|
2019
Q2 | $866K | Buy |
3,069
+237
| +8% | +$64.7K | 0.05% | 314 |
|
|
2019
Q1 | $813K | Sell |
2,832
-561
| -17% | -$162K | 0.05% | 321 |
|
|
2018
Q4 | $891K | Buy |
3,393
+512
| +18% | +$141K | 0.06% | 274 |
|
|
2018
Q3 | $789K | Buy |
2,881
+105
| +4% | +$27.3K | 0.04% | 324 |
|
|
2018
Q2 | $660K | Buy |
2,776
+99
| +4% | +$22.9K | 0.04% | 353 |
|
|
2018
Q1 | $588K | Sell |
2,677
-318
| -11% | -$74.7K | 0.04% | 337 |
|
|
2017
Q4 | $674K | Sell |
2,995
-50
| -2% | -$10.6K | 0.05% | 316 |
|
|
2017
Q3 | $578K | Sell |
3,045
-49
| -2% | -$9.33K | 0.04% | 338 |
|
|
2017
Q2 | $582K | Sell |
3,094
-363
| -11% | -$65.2K | 0.04% | 336 |
|
|
2017
Q1 | $572K | Buy |
3,457
+482
| +16% | +$76.7K | 0.04% | 327 |
|
|
2016
Q4 | $428K | Buy |
2,975
+88
| +3% | +$11.8K | 0.03% | 394 |
|
|
2016
Q3 | $361K | Sell |
2,887
-1,041
| -27% | -$134K | 0.03% | 417 |
|
|
2016
Q2 | $516K | Sell |
3,928
-604
| -13% | -$82.6K | 0.05% | 324 |
|
|
2016
Q1 | $630K | Sell |
4,532
-151
| -3% | -$20.2K | 0.06% | 284 |
|
|
2015
Q4 | $653K | Buy |
4,683
+885
| +23% | +$122K | 0.06% | 286 |
|
|
2015
Q3 | $532K | Sell |
3,798
-116
| -3% | -$17.4K | 0.06% | 288 |
|
|
2015
Q2 | $642K | Sell |
3,914
-414
| -10% | -$66.1K | 0.07% | 256 |
|
|
2015
Q1 | $668K | Buy |
4,328
+580
| +15% | +$82.6K | 0.07% | 258 |
|
|
2014
Q4 | $471K | Buy |
3,748
+874
| +30% | +$108K | 0.05% | 342 |
|
|
2014
Q3 | $344K | Sell |
2,874
-222
| -7% | -$25.5K | 0.04% | 384 |
|
|
2014
Q2 | $334K | Buy |
3,096
+198
| +7% | +$20.4K | 0.04% | 398 |
|
|
2014
Q1 | $289K | Buy |
2,898
+660
| +29% | +$59.7K | 0.04% | 416 |
|
|
2013
Q4 | $207K | Buy |
+2,238
| New | +$199K | 0.03% | 509 |
|
Other funds holding ELV
Raymond James Trust's ELV Position: Q3 2024 in Review
Raymond James Trust increased its Elevance Health (ELV) stake by 3.9% in Q3 2024, buying an estimated $104K and bringing the position to 5,180 shares worth $2.69M. The position accounts for 0.06% of the portfolio, ranked #281.
Raymond James Trust first reported a position in ELV in Q4 2013 and has held it in 44 quarters since. The position peaked at $2.72M in Q1 2024. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.
- Raymond James Trust held 5,180 shares of Elevance Health worth $2.69M as of Q3 2024.
- Raymond James Trust bought 195 Elevance Health shares in Q3 2024, an estimated $104K.
- Elevance Health made up 0.06% of Raymond James Trust's portfolio in Q3 2024, its #281 holding.
- Raymond James Trust first reported a position in Elevance Health in Q4 2013 and has held it in 44 quarters since.
- Raymond James Trust's Elevance Health position peaked at $2.72M in Q1 2024.
- 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.
Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.